PN0

Prinomastat

Created:2011-02-10
Last modified:  2021-03-13
Find related ligands:
Help
Chemical Details
Formal Charge0
Atom Count49
Chiral Atom Count1
Bond Count51
Aromatic Bond Count12
2D diagram of PN0
Toggle HydrogenToggle Labels
Chemical Component Summary
NamePrinomastat
Synonyms(3S)-N-hydroxy-2,2-dimethyl-4-{[4-(pyridin-4-yloxy)phenyl]sulfonyl}thiomorpholine-3-carboxamide
Systematic Name (OpenEye OEToolkits)(3S)-N-hydroxy-2,2-dimethyl-4-(4-pyridin-4-yloxyphenyl)sulfonyl-thiomorpholine-3-carboxamide
FormulaC18 H21 N3 O5 S2
Molecular Weight423.506
TypeNON-POLYMER
Chemical Descriptors
TypeProgramVersionDescriptor
SMILESACDLabs12.01O=S(=O)(N1C(C(=O)NO)C(SCC1)(C)C)c3ccc(Oc2ccncc2)cc3
SMILESCACTVS3.370CC1(C)SCCN([CH]1C(=O)NO)[S](=O)(=O)c2ccc(Oc3ccncc3)cc2
SMILESOpenEye OEToolkits1.7.0CC1(C(N(CCS1)S(=O)(=O)c2ccc(cc2)Oc3ccncc3)C(=O)NO)C
Canonical SMILESCACTVS3.370 CC1(C)SCCN([C@H]1C(=O)NO)[S](=O)(=O)c2ccc(Oc3ccncc3)cc2
Canonical SMILESOpenEye OEToolkits1.7.0 CC1([C@@H](N(CCS1)S(=O)(=O)c2ccc(cc2)Oc3ccncc3)C(=O)NO)C
InChIInChI1.03 InChI=1S/C18H21N3O5S2/c1-18(2)16(17(22)20-23)21(11-12-27-18)28(24,25)15-5-3-13(4-6-15)26-14-7-9-19-10-8-14/h3-10,16,23H,11-12H2,1-2H3,(H,20,22)/t16-/m0/s1
InChIKeyInChI1.03 YKPYIPVDTNNYCN-INIZCTEOSA-N
Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank IDDB05100 
NamePrinomastat
Groups investigational
DescriptionPrinomastat is a synthetic hydroxamic acid derivative with potential antineoplastic activity. Prinomastat inhibits matrix metalloproteinases (MMPs) (specifically, MMP-2, 9, 13, and 14), thereby inducing extracellular matrix degradation, and inhibiting angiogenesis, tumor growth and invasion, and metastasis. As a lipophilic agent, prinomastat crosses the blood-brain barrier.
Synonyms
  • Prinomastatum
  • Prinomastat
IndicationInvestigated for use/treatment in brain cancer, lung cancer, and prostate cancer.
Categories
  • Enzyme Inhibitors
  • Matrix Metalloproteinase Inhibitors
  • Protease Inhibitors
CAS number192329-42-3

Drug Targets

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
NameTarget SequencePharmacological ActionActions
MatrilysinMRLTVLCAVCLLPGSLALPLPQEAGGMSELQWEQAQDYLKRFYLYDSETK...unknowninhibitor
Interstitial collagenaseMHSFPPLLLLLFWGVVSHSFPATLETQEQDVDLVQKYLEKYYNLKNDGRQ...unknowninhibitor
72 kDa type IV collagenaseMEALMARGALTGPLRALCLLGCLLSHAAAAPSPIIKFPGDVAPKTDKELA...unknowninhibitor
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
Pharos CHEMBL75094
PubChem 466151
ChEMBL CHEMBL75094
ChEBI CHEBI:138885